• Explore /
  • Poster
  • / Phase Ib study of RO5137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170).

Phase Ib study of RO5137382/GC33 in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC) (NCT00976170).

Abstract Poster

Authors

Ghassan Abou-Alfa

Ghassan K. Abou-Alfa

Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY

Ghassan K. Abou-Alfa , Chia-Jui Yen , Jorge A. Carrasquillo , Chih-Hung Hsu , Bolorsukh Gansukh , Jennifer Ma , Ellen Hollywood , Peter J Wan , Yu Yun Shao , Zhong-Zhe Lin , Catherine Frenette , Bert H. O'Neil , Lawrence H. Schwartz , Toshihiko Ohtomo , Takayoshi Tanaka , Ya-Chi Chen , Stacey Ukrainskyj , Leonard Saltz , Reuy-min Lee , Ann-Lii Cheng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT00976170

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 4100)

DOI

10.1200/jco.2014.32.15_suppl.4100

Abstract #

4100

Poster Bd #

187

Abstract Disclosures

Similar Posters

Poster

2013 Gastrointestinal Cancers Symposium

A phase I study of GC33 in Japanese patients with advanced hepatocellular carcinoma (HCC).

A phase I study of GC33 in Japanese patients with advanced hepatocellular carcinoma (HCC).

First Author: Takuji Okusaka

First Author: Weijia Fang

First Author: David Shao Peng Tan

First Author: Jinpeng Li